+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Advances in Clinical Oncology · Registering as Listener

IACO
📅 3 – 4 Mar 2027 📍 Markham, Canada 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Advances in Clinical Oncology
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 10

This track focuses on the latest advancements in cancer treatment modalities, including chemotherapy, radiotherapy, and surgical interventions. Participants will explore novel therapeutic approaches and their implications for patient outcomes.

This session emphasizes the importance of translational research in oncology, highlighting how laboratory discoveries can be effectively applied to clinical settings. Discussions will include case studies that demonstrate successful translation of research findings into therapeutic strategies.

This track will delve into the evolving landscape of immunotherapy, examining the mechanisms of action and clinical applications of immune checkpoint inhibitors and CAR T-cell therapies. Experts will discuss challenges and opportunities in enhancing patient responses.

Focusing on the role of genomics and molecular profiling, this session will explore how precision medicine is transforming cancer treatment paradigms. Attendees will learn about personalized therapeutic strategies tailored to individual patient profiles.

This track investigates the underlying biological mechanisms of tumor development and progression, with a focus on identifying novel therapeutic targets. Researchers will present findings that could lead to innovative treatment options.

This session addresses the critical aspects of patient care in oncology, including symptom management, psychosocial support, and survivorship issues. Discussions will highlight strategies to enhance the quality of life for cancer patients and their families.

This track examines the intersection of health policy and oncology, focusing on the implications of policy decisions on cancer care delivery and access to treatment. Participants will engage in discussions about advocacy and the role of policy in shaping cancer research funding.

This session will explore the impact of emerging technologies, such as artificial intelligence and telemedicine, on cancer diagnosis and treatment. Experts will discuss how these innovations can improve patient outcomes and streamline clinical workflows.

Focusing on the design and implementation of clinical trials in oncology, this track will cover best practices and innovative methodologies. Researchers will share insights on overcoming challenges in trial execution and patient recruitment.

This session will address the specific challenges faced in pediatric oncology, including treatment protocols and long-term effects of therapy. Experts will discuss recent advances in the field and the importance of tailored approaches for young patients.

This track highlights international collaborations and research initiatives aimed at addressing cancer disparities worldwide. Participants will explore how global partnerships can enhance cancer research and improve outcomes in diverse populations.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED